These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

457 related items for PubMed ID: 28024723

  • 1. The prevalence and risk factors associated with osteoradionecrosis of the jaw in oral and oropharyngeal cancer patients treated with intensity-modulated radiation therapy (IMRT): The Memorial Sloan Kettering Cancer Center experience.
    Owosho AA, Tsai CJ, Lee RS, Freymiller H, Kadempour A, Varthis S, Sax AZ, Rosen EB, Yom SK, Randazzo J, Drill E, Riedel E, Patel S, Lee NY, Huryn JM, Estilo CL.
    Oral Oncol; 2017 Jan; 64():44-51. PubMed ID: 28024723
    [Abstract] [Full Text] [Related]

  • 2. Osteoradionecrosis of the mandible in patients with oropharyngeal carcinoma treated with intensity-modulated radiotherapy.
    Caparrotti F, Huang SH, Lu L, Bratman SV, Ringash J, Bayley A, Cho J, Giuliani M, Kim J, Waldron J, Hansen A, Tong L, Xu W, O'Sullivan B, Wood R, Goldstein D, Hope A.
    Cancer; 2017 Oct 01; 123(19):3691-3700. PubMed ID: 28608925
    [Abstract] [Full Text] [Related]

  • 3. Risk factors and dose-effect relationship for mandibular osteoradionecrosis in oral and oropharyngeal cancer patients.
    Lee IJ, Koom WS, Lee CG, Kim YB, Yoo SW, Keum KC, Kim GE, Choi EC, Cha IH.
    Int J Radiat Oncol Biol Phys; 2009 Nov 15; 75(4):1084-91. PubMed ID: 19327914
    [Abstract] [Full Text] [Related]

  • 4. Dose-volume correlates of mandibular osteoradionecrosis in Oropharynx cancer patients receiving intensity-modulated radiotherapy: Results from a case-matched comparison.
    MD Anderson Head and Neck Cancer Symptom Working Group.
    Radiother Oncol; 2017 Aug 15; 124(2):232-239. PubMed ID: 28733053
    [Abstract] [Full Text] [Related]

  • 5. Potential risk factors for jaw osteoradionecrosis after radiotherapy for head and neck cancer.
    Kuhnt T, Stang A, Wienke A, Vordermark D, Schweyen R, Hey J.
    Radiat Oncol; 2016 Jul 30; 11():101. PubMed ID: 27473433
    [Abstract] [Full Text] [Related]

  • 6. Risk-adapted dental care prior to intensity-modulated radiotherapy (IMRT).
    Studer G, Glanzmann C, Studer SP, Grätz KW, Bredell M, Locher M, Lütolf UM, Zwahlen RA.
    Schweiz Monatsschr Zahnmed; 2011 Jul 30; 121(3):216-29. PubMed ID: 21534021
    [Abstract] [Full Text] [Related]

  • 7. Risk factors for osteoradionecrosis of the jaw in patients with head and neck squamous cell carcinoma.
    Kubota H, Miyawaki D, Mukumoto N, Ishihara T, Matsumura M, Hasegawa T, Akashi M, Kiyota N, Shinomiya H, Teshima M, Nibu KI, Sasaki R.
    Radiat Oncol; 2021 Jan 05; 16(1):1. PubMed ID: 33402192
    [Abstract] [Full Text] [Related]

  • 8. Osteoradionecrosis of the Jaw Following Proton Radiation Therapy for Patients With Head and Neck Cancer.
    Singh A, Kitpanit S, Neal B, Yorke E, White C, Yom SK, Randazzo JD, Wong RJ, Huryn JM, Tsai CJ, Zakeri K, Lee NY, Estilo CL.
    JAMA Otolaryngol Head Neck Surg; 2023 Feb 01; 149(2):151-159. PubMed ID: 36547968
    [Abstract] [Full Text] [Related]

  • 9. Is the Risk to Develop Osteoradionecrosis of the Jaws Following IMRT for Head and Neck Cancer Related to Co-Factors?
    Rosenfeld E, Eid B, Masri D, Popovtzer A, Mizrachi A, Chaushu G.
    Medicina (Kaunas); 2021 May 11; 57(5):. PubMed ID: 34064551
    [Abstract] [Full Text] [Related]

  • 10. Incidence of, and risk factors for, mandibular osteoradionecrosis in patients with oral cavity and oropharynx cancers.
    Moon DH, Moon SH, Wang K, Weissler MC, Hackman TG, Zanation AM, Thorp BD, Patel SN, Zevallos JP, Marks LB, Chera BS.
    Oral Oncol; 2017 Sep 11; 72():98-103. PubMed ID: 28797468
    [Abstract] [Full Text] [Related]

  • 11. Symptom burden and dysphagia associated with osteoradionecrosis in long-term oropharynx cancer survivors: A cohort analysis.
    Wong ATT, Lai SY, Gunn GB, Beadle BM, Fuller CD, Barrow MP, Hofstede TM, Chambers MS, Sturgis EM, Mohamed ASR, Lewin JS, Hutcheson KA.
    Oral Oncol; 2017 Mar 11; 66():75-80. PubMed ID: 28249651
    [Abstract] [Full Text] [Related]

  • 12. Relationship between oral health status and development of osteoradionecrosis of the mandible: a retrospective longitudinal study.
    Katsura K, Sasai K, Sato K, Saito M, Hoshina H, Hayashi T.
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2008 Jun 11; 105(6):731-8. PubMed ID: 18329913
    [Abstract] [Full Text] [Related]

  • 13. Objective assessment of trismus in oral and oropharyngeal cancer patients treated with intensity-modulated radiation therapy (IMRT).
    Owosho AA, Pedreira Ramalho LM, Rosenberg HI, Yom SK, Drill E, Riedel E, Tsai CJ, Lee NY, Huryn JM, Estilo CL.
    J Craniomaxillofac Surg; 2016 Sep 11; 44(9):1408-13. PubMed ID: 27377999
    [Abstract] [Full Text] [Related]

  • 14. The incidence of osteoradionecrosis of the jaws in oral cavity cancer patients treated with intensity-modulated radiotherapy: a systematic review and meta-analysis.
    de Almeida-Silva LA, Lupp JDS, Sobral-Silva LA, Dos Santos LAR, Marques TO, da Silva DBR, Caneppele TMF, Bianchi-de-Moraes M.
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2024 Jul 11; 138(1):66-78. PubMed ID: 38772792
    [Abstract] [Full Text] [Related]

  • 15. Accounting for fractionation and heterogeneous dose distributions in the modelling of osteoradionecrosis in oropharyngeal carcinoma treatment.
    Verduijn GM, Sijtsema ND, van Norden Y, Heemsbergen WD, Mast H, Sewnaik A, Chin D, Baker S, Capala ME, van der Lugt A, van Meerten E, Hoogeman MS, Petit SF.
    Radiother Oncol; 2023 Nov 11; 188():109889. PubMed ID: 37659662
    [Abstract] [Full Text] [Related]

  • 16. Risk profile for osteoradionecrosis of the mandible in the IMRT era.
    Studer G, Bredell M, Studer S, Huber G, Glanzmann C.
    Strahlenther Onkol; 2016 Jan 11; 192(1):32-9. PubMed ID: 26265308
    [Abstract] [Full Text] [Related]

  • 17. Osteoradionecrosis of the mandible after radiotherapy for head and neck cancer: risk factors and dose-volume correlations.
    Aarup-Kristensen S, Hansen CR, Forner L, Brink C, Eriksen JG, Johansen J.
    Acta Oncol; 2019 Oct 11; 58(10):1373-1377. PubMed ID: 31364903
    [Abstract] [Full Text] [Related]

  • 18. Intensity-modulated proton therapy and osteoradionecrosis in oropharyngeal cancer.
    Zhang W, Zhang X, Yang P, Blanchard P, Garden AS, Gunn B, Fuller CD, Chambers M, Hutcheson KA, Ye R, Lai SY, Radwan MAS, Zhu XR, Frank SJ.
    Radiother Oncol; 2017 Jun 11; 123(3):401-405. PubMed ID: 28549794
    [Abstract] [Full Text] [Related]

  • 19. Risk factor assessment for the development of osteoradionecrosis.
    Goldwaser BR, Chuang SK, Kaban LB, August M.
    J Oral Maxillofac Surg; 2007 Nov 11; 65(11):2311-6. PubMed ID: 17954330
    [Abstract] [Full Text] [Related]

  • 20. Patient and treatment-related risk factors for osteoradionecrosis of the jaw in patients with head and neck cancer.
    Raguse JD, Hossamo J, Tinhofer I, Hoffmeister B, Budach V, Jamil B, Jöhrens K, Thieme N, Doll C, Nahles S, Hartwig ST, Stromberger C.
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2016 Mar 11; 121(3):215-21.e1. PubMed ID: 26703417
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.